Popis s procjenom regulatornih potreba

Popis s procjenom regulatornih potreba

The assessment of regulatory needs list includes substances for which an assessment either is under development or has been completed. 

For each substance, the table shows the assessing authority (submitter), the concern, the status and the suggested follow-up action, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

Regulatory Management Option Analysis (RMOA) are assessments of regulatory needs. Publication of RMOA was initiated in February 2013 with the start of the implementation of the SVHC Roadmap. In 2019, authorities and in particular ECHA have moved to address more groups of substances.

The responsibility for the content of an assessment of regulatory needs rests with the authority that developed it. It is possible that other authorities do not have the same view and may develop a further assessment of regulatory needs for the same (group of) substances. Assessment of regulatory needs and their conclusions are compiled based on available information and may change in light of new information or further assessment.  

Last updated 16 svibnja 2024. Database contains 5055 unique substances/entries.
Filter the list
Foreseen regulatory need:
Date of intention:
Date of assessment:
Latest update:

The List does not contain any Substances.
 
235-715-9
12607-70-4
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
No suggestion yet
Details
246-678-3
25155-25-3
Netherlands
Bioaccumulation
Persistence
Toxic for reproduction
Under development
No suggestion yet
Details
677-811-7
207386-91-2
Denmark
Endocrine disruption
Mutagenic
Toxic for reproduction
Under development
No suggestion yet
Details
217-533-1
1879-09-0
France
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Under development
No suggestion yet
Details
701-118-1
2156592-54-8
Austria
Toxic for reproduction
Under development
No suggestion yet
Details
204-327-1
119-47-1
Denmark
Toxic for reproduction
Concluded
SVHC
14-lip-2021
Details
202-696-3
98-73-7
Belgium
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
None
23-ruj-2014
Details
209-544-5
584-84-9
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Restriction
23-ruj-2014
Details
201-250-5
80-09-1
Belgium
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
SVHC
26-ruj-2022
Details
254-551-9
39635-79-5
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Pending
No suggestion yet
23-ruj-2014
Details
202-966-0
101-68-8
Denmark
Carcinogenic
Mutagenic
Other human toxicity
Persistence
Toxic for reproduction
Concluded
None
23-ruj-2014
Details
201-245-8
80-05-7
France
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
SVHC
15-kol-2017
Details
211-765-7
693-98-1
Sweden
Toxic for reproduction
Concluded
SVHC
16-pro-2019
Details
202-039-0
91-08-7
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
None
23-ruj-2014
Details
ACETOCURE 97; GENOCURE*PMP; IGM 4817; IRGACURE 907; SPEEDCURE 97
400-600-6
71868-10-5
Austria
Toxic for reproduction
Concluded
SVHC
08-srp-2019
Details
203-772-9
110-49-6
Sweden
Toxic for reproduction
Concluded
SVHC
29-stu-2018
Details
239-622-4
15571-58-1
Austria
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
SVHC
23-ruj-2014
Details
CG 25-369; IRGACURE 369; TK 11-319
404-360-3
119313-12-1
Austria
Toxic for reproduction
Concluded
SVHC
08-srp-2019
Details
438-340-0
119344-86-4
Austria
Toxic for reproduction
Concluded
SVHC
29-lip-2023
Details
201-289-8
80-54-6
Sweden
Toxic for reproduction
Concluded
SVHC
25-lip-2019
Details
201-841-8
88-58-4
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
None
23-ruj-2014
Details
221-967-7
3296-90-0
Norway
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
SVHC
03-srp-2018
Details
AP-5
401-720-1
6807-17-6
Sweden
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
SVHC
17-svi-2018
Details
219-799-4
2536-05-2
Denmark
Carcinogenic
Mutagenic
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
None
23-ruj-2014
Details
201-236-9
79-94-7
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Pending
No suggestion yet
01-tra-2015
Details
214-012-0
1072-63-5
Sweden
Toxic for reproduction
Concluded
SVHC
16-pro-2019
Details
212-828-1
872-50-4
Commission
Toxic for reproduction
Concluded
Restriction
25-lis-2018
Details
203-439-8
106-89-8
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
No suggestion yet
Details
240-260-4
16096-31-4
Denmark
Persistence
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
None
23-ruj-2014
Details
221-641-4
3173-72-6
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Restriction
23-ruj-2014
Details
214-317-9
1120-71-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
SVHC
06-velj-2015
Details
203-002-1
102-06-7
France
Other environmental toxicity
Other human toxicity
Toxic for reproduction
Under development
No suggestion yet
Details
203-002-1
102-06-7
France
Toxic for reproduction
Under development
No suggestion yet
Details
211-463-5
646-06-0
Germany
Toxic for reproduction
Concluded
CLH
15-pro-2022
Details
201-152-2
78-87-5
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
No suggestion yet
Details
203-444-5
106-93-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Other
Other legislation
07-kol-2015
Details
431-890-2
166412-78-8
France
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
None
15-ožu-2016
Details
271-094-0
68515-51-5
Sweden
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
SVHC
13-sij-2015
Details
230-528-9
7173-62-8
Ireland
Bioaccumulation
Carcinogenic
Endocrine disruption
Mutagenic
Persistence
Respiratory sensitiser
STOT RE
Skin sensitiser
Toxic for reproduction
Concluded
None
05-srp-2023
Details
246-932-3
25387-93-3
Denmark
Endocrine disruption
Mutagenic
Toxic for reproduction
Under development
No suggestion yet
Details
-
36505-83-6
Ireland
Bioaccumulation
Carcinogenic
Endocrine disruption
Mutagenic
Persistence
Respiratory sensitiser
STOT RE
Skin sensitiser
Toxic for reproduction
Concluded
None
05-srp-2023
Details
265-004-9
64665-57-2
Germany
To be defined
Concluded
CLH
SVHC
20-pro-2023
Details
931-891-2
-
Germany
To be defined
Concluded
CLH
SVHC
20-pro-2023
Details
249-596-6
29385-43-1
Germany
To be defined
Concluded
CLH
SVHC
20-pro-2023
Details
show/hide
Asbestos, actinolite EC / List no: 616-471-6 | CAS no: 77536-66-4
Asbestos, tremolite EC / List no: 616-473-7 | CAS no: 77536-68-6
Asbestos, crocidolite EC / List no: 601-649-8 | CAS no: 12001-28-4
Asbestos, amosite EC / List no: 601-801-3 | CAS no: 12172-73-5
Asbestos, chrysotile EC / List no: 601-650-3 | CAS no: 12001-29-5
Asbestos, anthophyllite EC / List no: 616-472-1 | CAS no: 77536-67-5
-
-
Netherlands
To be defined
Under development
No suggestion yet
Details
205-265-8
136-85-6
Germany
To be defined
Concluded
CLH
SVHC
20-pro-2023
Details
265-002-8
64665-53-8
Germany
To be defined
Concluded
CLH
SVHC
20-pro-2023
Details
239-487-1
15468-32-3
Netherlands
STOT RE
Concluded
Restriction
Other legislation
10-ožu-2023
Details
238-877-9
14807-96-6
Netherlands
Carcinogenic
STOT RE
Concluded
CLH
Other
10-pro-2021
Details
202-851-5
100-42-5
Netherlands
STOT RE
Concluded
CLH
SVHC
Other
13-svi-2022
Details

Export search results to: